GlaxoSmithKline PLC Director/PDMR Shareholding (9403H)

TIDMGSK

RNS Number : 9403H

GlaxoSmithKline PLC

23 August 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ====================================================================== 
 a)   Name                     Dr K Slaoui 
===  ========================  ============================================ 
 b)   Position/status          PCA of Dr M M Slaoui (Chairman, Global 
                                Vaccines) 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of           GlaxoSmithKline plc American Depositary 
       the financial            Shares ('ADSs') 
       instrument               ISIN: US37733W1053 
===  ========================  ============================================ 
 b)   Nature of the             An increase of 1 ADS following the notional 
       transaction               allocation of ADSs on 22 August 2016, at 
                                 a price of $44.12 per ADS, as a result 
                                 of the revaluation of the cash element 
                                 of the notional investment held within 
                                 the GSK 401(K) plan. 
===  ========================  ============================================ 
 c)   Price(s) and              Price(s)   Volume(s) 
       volume(s)                ---------  ---------- 
                                 $44.12     1 
                                ---------  ---------- 
===  ========================  ============================================ 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  ============================================ 
 e)   Date of the transaction  2016-08-22 
===  ========================  ============================================ 
 f)   Place of the              n/a 
       transaction 
===  ========================  ============================================ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHZXLFLQVFZBBX

(END) Dow Jones Newswires

August 23, 2016 10:45 ET (14:45 GMT)